Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease
The aims of this study are to create a prospective data base to evaluate the long term outcomes of medical and surgical treatment of gastroesophageal reflux disease (GERD); to measure standard outcomes as well as patient derived outcomes such as general and disease specific quality of life (QOL) issues and patient satisfaction; to refine the parameters that may identify patients who will benefit from surgery for GERD; and to identify possible determinants of failure of both medical and surgical treatments of reflux.
• Patients with reflux symptoms present for at least 6 months, caused by documented reflux. Reflux symptoms include:
‣ heartburn
⁃ acid regurgitation
⁃ waterbrash
⁃ non-cardiac chest pain
⁃ dyspepsia
• Reflux diagnosis either by endoscopy, upper gastrointestinal (GI), or 24 hour pH.
• Patients scheduled for surgical management of GERD and/or hiatal hernia
• Patients currently or commencing treatment with at least proton pump inhibitors or pro-motility agents.